Browsing: CoExclusive

AI & Future Tech

Pathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic

By TheWireHub.netAugust 4, 20260

NEW YORK–(BUSINESS WIRE)–Aug 3, 2026–Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today…